BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36412434)

  • 1. Bone scan index on bone scintigraphy and radiation therapy for bone metastases from cancers other than prostate and breast cancers: A retrospective observational study.
    Ishibashi N; Maebayashi T; Kimura Y; Okada M
    J Cancer Res Ther; 2022; 18(6):1716-1721. PubMed ID: 36412434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONEⓇ Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.
    Higashiyama S; Yoshida A; Kawabe J
    Urol Int; 2022; 106(9):963-969. PubMed ID: 35249033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
    Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients.
    Motegi K; Miyaji N; Yamashita K; Koizumi M; Terauchi T
    Ann Nucl Med; 2022 Sep; 36(9):834-841. PubMed ID: 35773557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
    Higashiyama S; Yoshida A; Kawabe J
    Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Scan Index Is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: A Prospective Study.
    Zacho HD; Gade M; Mortensen JC; Bertelsen H; Boldsen SK; Barsi T; Petersen LJ
    Urology; 2017 Oct; 108():135-141. PubMed ID: 28760556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods.
    Takahashi Y; Yoshimura M; Suzuki K; Hashimoto T; Hirose H; Uchida K; Inoue S; Koizumi K; Tokuuye K
    Ann Nucl Med; 2012 Aug; 26(7):586-93. PubMed ID: 22744807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).
    Armstrong AJ; Kaboteh R; Carducci MA; Damber JE; Stadler WM; Hansen M; Edenbrandt L; Forsberg G; Nordle Ö; Pili R; Morris MJ
    Urol Oncol; 2014 Nov; 32(8):1308-16. PubMed ID: 25240761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fully automated analysis for bone scintigraphy with artificial neural network: usefulness of bone scan index (BSI) in breast cancer.
    Inaki A; Nakajima K; Wakabayashi H; Mochizuki T; Kinuya S
    Ann Nucl Med; 2019 Oct; 33(10):755-765. PubMed ID: 31317398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of computer-assisted analysis of skeletal lesions for the staging of prostate cancer.
    Petersen LJ; Mortensen JC; Bertelsen H; Zacho HD
    BMC Med Imaging; 2017 Jul; 17(1):40. PubMed ID: 28693433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a software for semi-automatically calculating the bone scan index on bone scintigraphy scans.
    Yoshida A; Higashiyama S; Kawabe J
    Clin Imaging; 2021 Oct; 78():14-18. PubMed ID: 33714920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy.
    Kadomoto S; Yaegashi H; Nakashima K; Iijima M; Kawaguchi S; Nohara T; Shigehara K; Izumi K; Kadono Y; Nakajima K; Mizokami A
    Anticancer Res; 2019 May; 39(5):2553-2559. PubMed ID: 31092452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer.
    Reza M; Kaboteh R; Sadik M; Bjartell A; Wollmer P; Trägårdh E
    BMC Med Imaging; 2018 May; 18(1):8. PubMed ID: 29728144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of a computer-aided diagnosis system for whole-body bone scintigraphy to detect bone metastasis in breast cancer patients.
    Urano M; Maki Y; Nishikawa H; Kawai T; Shiraki N; Shibamoto Y
    Ann Nucl Med; 2017 Jan; 31(1):40-45. PubMed ID: 27686468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of spatially adaptive noise reduction processing in computer-assisted diagnosis system for bone scintigraphy].
    Ichikawa H; Onoguchi M; Okuda K; Kato T; Terabe M; Shimada H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 May; 70(5):461-6. PubMed ID: 24858291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Segmented linear correlations between bone scan index and prostate cancer biomarkers, alkaline phosphatase, and prostate specific antigen in patients with a Gleason score ≥7.
    Ebrahim T; Hadebe B; Aldous C; Tinarwo P; Nyakale N
    Medicine (Baltimore); 2022 Jun; 101(25):e29515. PubMed ID: 35758394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the bone scan index using a computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases.
    Miyoshi Y; Yoneyama S; Kawahara T; Hattori Y; Teranishi J; Kondo K; Moriyama M; Takebayashi S; Yokomizo Y; Yao M; Uemura H; Noguchi K
    BMC Cancer; 2016 Feb; 16():128. PubMed ID: 26896160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Scan Index predicts outcome in patients with metastatic hormone-sensitive prostate cancer.
    Poulsen MH; Rasmussen J; Edenbrandt L; Høilund-Carlsen PF; Gerke O; Johansen A; Lund L
    BJU Int; 2016 May; 117(5):748-53. PubMed ID: 25906907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.